| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-554
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5084 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-554
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-50 |
| filingDate |
1995-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1999-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35001ca8bd47d22a9c1a0b5e15fe58fa |
| publicationDate |
1999-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-5968552-A |
| titleOfInvention |
Diltiazem hydrochloride formulation |
| abstract |
PCT No. PCT/CA95/00674 Sec. 371 Date Jun. 2, 1997 Sec. 102(e) Date Jun. 2, 1997 PCT Filed Dec. 1, 1995 PCT Pub. No. WO96/17598 PCT Pub. Date Jun. 13, 1996The invention relates to a pharmaceutical formulation comprising diltiazem hydrochloride. The formulation is in the form of a mixture of beads blended so as to provide a dissolution profile that renders the formulation suitable for oral administration once daily. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6033687-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6635277-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9555004-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9549940-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9622983-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10314790-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6214385-B1 |
| priorityDate |
1994-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |